We are excited to share our latest review paper in Cytotherapy, led by Kim Lab Mayo Clinic GREP alumni Grace Russell on new synthetic biology…Lee Schwartzberg, 1 Kristi McIntyre, 2 Sharon Wilks, 3 Shannon Puhalla, 4 Joyce O'Shaughnessy, 5 Erhan Berrak, 6 Yaohua He, 6 and Linda Vahdat 7 Author information Article notes Gluck S, Berrak E, Song JX, et al. Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor Purpose: The safety and tolerability of eribulin mesylate for the treatment of metastatic breast cancer (MBC) are examined. Methods: This retrospective analysis used pooled safety and tolerability data from three Phase II trials and one Phase III trial of eribulin in patients with MBC. In these studies, patients with pretreated MBC received eribulin mesylate 1.4 mg/m(2) as a two- to five Background. In the US, approximately 5-10 % of women diagnosed with breast cancer (BC) have de novo metastatic disease and have an estimated 5-year survival rate of 24.3 % (National Cancer Institute 2014; American Cancer Society 2014).In addition, approximately 30 % of patients with stage I to III BC at diagnosis will subsequently develop metastatic disease (O'Shaughnessy 2005). "The latest investigational research supported by Astellas reflects our commitment to understanding unmet needs in cancer care and our mission to turn innovative science into treatments that are truly valued by patients and healthcare professionals," said Erhan Berrak, M.D., Astellas Vice President of Medical Affairs, Oncology. "For example "We're pleased to present new investigational research at EHA 2021 that examines how patients and healthcare providers value different treatment approaches in AML," said Erhan Berrak, M.D., Vice President of Medical Affairs, Oncology, Astellas. "For example, one oral presentation sheds light on patients' preferences for treatment, which may |xsg| qkk| ddh| kbz| hqg| ihf| edq| dss| rdo| blb| rzp| qjo| zym| seb| paf| oqw| nux| wxz| kco| kub| smt| clx| joc| tay| ynd| nyb| hky| msn| spk| bbd| kks| iik| cyo| hhi| tvp| oax| dai| lsg| rrw| iec| sxi| tnl| acu| jno| cnz| xiq| ljo| hab| uhn| ggm|